Posted in | News | Gold | Silver

Golden Minerals Updates First Quarter 2012 Production for Velardena Operations

Golden Minerals, a Colorado-based company, announced that it has revised the Q1 2012 production from the Velardeña operations and also provided a revised production guidance for fiscal year 2012.

Compared to the initial results released earlier, Q1 2012 production from the Velardeña operations was significantly better. Production for the quarter was about 110,000 oz of silver and 1,700 oz of gold, surpassing production guidance by nearly 22% for silver and 30% for gold.

For the remaining three quarters of 2012, production guidance has been revised with a minor decrease in expected silver production and a minor increase in expected gold production. For 2012, payable gold production guidance is about 9,400 oz against earlier production guidance of 9,000 oz, and payable silver production guidance is likely to be 590,000 oz against earlier production guidance of 740,000 oz.

For 2012, the drop in expected silver production was because of a delay in the proposed arrival of mobile mining and supplementary equipment, and this delay brought down the amount of mine development, which further delayed access to high-grade slopes and further reductions in dilution. Gold production is projected to remain close to the earlier production guidance as the firm intends to use the latest bulk flotation process that is being deployed at the oxide plant to enhance gold recoveries.

Golden Minerals is performing engineering studies on various alternatives for a potential phased expansion of production at the Velardeña operations, instead of the 1,300 tons per day expansion that is being assessed. For 1,300 tons per day alternative, the company is anticipating roughly $20 million. The timing of a possible expansion will depend on the availability of funds.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Golden Minerals Updates First Quarter 2012 Production for Velardena Operations. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=6329.

  • MLA

    Scanlon, Joel. "Golden Minerals Updates First Quarter 2012 Production for Velardena Operations". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=6329>.

  • Chicago

    Scanlon, Joel. "Golden Minerals Updates First Quarter 2012 Production for Velardena Operations". AZoMining. https://www.azomining.com/News.aspx?newsID=6329. (accessed November 21, 2024).

  • Harvard

    Scanlon, Joel. 2019. Golden Minerals Updates First Quarter 2012 Production for Velardena Operations. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=6329.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.